Chuan Li1, Lili Qu1, Alyssa J Matz1, Patrick A Murphy2,3, Yongmei Liu4, Ani W Manichaikul5, Derek Aguiar6, Stephen S Rich5, David M Herrington7, David Vu8, W Craig Johnson8, Jerome I Rotter9, Wendy S Post1,3, Anthony T Vella1,10, Annabelle Rodriguez-Oquendo2, Beiyan Zhou1,10. 1. Department of Immunology (C.L., L.Q., A.J.M., A.T.V., B.Z.), University of Connecticut, Farmington. 2. Center for Vascular Biology (P.A.M., A.R.-O.), University of Connecticut, Farmington. 3. Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD (P.A.M., W.S.P.). 4. Department of Medicine, Divisions of Cardiology and Neurology, Duke University Medical Center, Durham, NC (Y.L.). 5. Center for Public Health Genomics, Department of Public Health Sciences, University of Virginia, Charlottesville (A.W.M., S.S.R.). 6. Department of Computer Science and Engineering, University of Connecticut, Storrs (D.A.). 7. Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC (D.M.H.). 8. Department of Biostatistics, University of Washington, Seattle (D.V., W.C.J.). 9. Institute for Translational Genomics and Population Sciences, Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA (J.I.R.). 10. School of Medicine, and Institute for Systems Genomics (A.T.V., B.Z.), University of Connecticut, Farmington.
Abstract
BACKGROUND: Whereas several interventions can effectively lower lipid levels in people at risk for atherosclerotic cardiovascular disease (ASCVD), cardiovascular event risks remain, suggesting an unmet medical need to identify factors contributing to cardiovascular event risk. Monocytes and macrophages play central roles in atherosclerosis, but studies have yet to provide a detailed view of macrophage populations involved in increased ASCVD risk. METHODS: A novel macrophage foaming analytics tool, AtheroSpectrum, was developed using 2 quantitative indices depicting lipid metabolism and the inflammatory status of macrophages. A machine learning algorithm was developed to analyze gene expression patterns in the peripheral monocyte transcriptome of MESA participants (Multi-Ethnic Study of Atherosclerosis; set 1; n=911). A list of 30 genes was generated and integrated with traditional risk factors to create an ASCVD risk prediction model (30-gene cardiovascular disease risk score [CR-30]), which was subsequently validated in the remaining MESA participants (set 2; n=228); performance of CR-30 was also tested in 2 independent human atherosclerotic tissue transcriptome data sets (GTEx [Genotype-Tissue Expression] and GSE43292). RESULTS: Using single-cell transcriptomic profiles (GSE97310, GSE116240, GSE97941, and FR-FCM-Z23S), AtheroSpectrum detected 2 distinct programs in plaque macrophages-homeostatic foaming and inflammatory pathogenic foaming-the latter of which was positively associated with severity of atherosclerosis in multiple studies. A pool of 2209 pathogenic foaming genes was extracted and screened to select a subset of 30 genes correlated with cardiovascular event in MESA set 1. A cardiovascular disease risk score model (CR-30) was then developed by incorporating this gene set with traditional variables sensitive to cardiovascular event in MESA set 1 after cross-validation generalizability analysis. The performance of CR-30 was then tested in MESA set 2 (P=2.60×10-4; area under the receiver operating characteristic curve, 0.742) and 2 independent data sets (GTEx: P=7.32×10-17; area under the receiver operating characteristic curve, 0.664; GSE43292: P=7.04×10-2; area under the receiver operating characteristic curve, 0.633). Model sensitivity tests confirmed the contribution of the 30-gene panel to the prediction model (likelihood ratio test; df=31, P=0.03). CONCLUSIONS: Our novel computational program (AtheroSpectrum) identified a specific gene expression profile associated with inflammatory macrophage foam cells. A subset of 30 genes expressed in circulating monocytes jointly contributed to prediction of symptomatic atherosclerotic vascular disease. Incorporating a pathogenic foaming gene set with known risk factors can significantly strengthen the power to predict ASCVD risk. Our programs may facilitate both mechanistic investigations and development of therapeutic and prognostic strategies for ASCVD risk.
BACKGROUND: Whereas several interventions can effectively lower lipid levels in people at risk for atherosclerotic cardiovascular disease (ASCVD), cardiovascular event risks remain, suggesting an unmet medical need to identify factors contributing to cardiovascular event risk. Monocytes and macrophages play central roles in atherosclerosis, but studies have yet to provide a detailed view of macrophage populations involved in increased ASCVD risk. METHODS: A novel macrophage foaming analytics tool, AtheroSpectrum, was developed using 2 quantitative indices depicting lipid metabolism and the inflammatory status of macrophages. A machine learning algorithm was developed to analyze gene expression patterns in the peripheral monocyte transcriptome of MESA participants (Multi-Ethnic Study of Atherosclerosis; set 1; n=911). A list of 30 genes was generated and integrated with traditional risk factors to create an ASCVD risk prediction model (30-gene cardiovascular disease risk score [CR-30]), which was subsequently validated in the remaining MESA participants (set 2; n=228); performance of CR-30 was also tested in 2 independent human atherosclerotic tissue transcriptome data sets (GTEx [Genotype-Tissue Expression] and GSE43292). RESULTS: Using single-cell transcriptomic profiles (GSE97310, GSE116240, GSE97941, and FR-FCM-Z23S), AtheroSpectrum detected 2 distinct programs in plaque macrophages-homeostatic foaming and inflammatory pathogenic foaming-the latter of which was positively associated with severity of atherosclerosis in multiple studies. A pool of 2209 pathogenic foaming genes was extracted and screened to select a subset of 30 genes correlated with cardiovascular event in MESA set 1. A cardiovascular disease risk score model (CR-30) was then developed by incorporating this gene set with traditional variables sensitive to cardiovascular event in MESA set 1 after cross-validation generalizability analysis. The performance of CR-30 was then tested in MESA set 2 (P=2.60×10-4; area under the receiver operating characteristic curve, 0.742) and 2 independent data sets (GTEx: P=7.32×10-17; area under the receiver operating characteristic curve, 0.664; GSE43292: P=7.04×10-2; area under the receiver operating characteristic curve, 0.633). Model sensitivity tests confirmed the contribution of the 30-gene panel to the prediction model (likelihood ratio test; df=31, P=0.03). CONCLUSIONS: Our novel computational program (AtheroSpectrum) identified a specific gene expression profile associated with inflammatory macrophage foam cells. A subset of 30 genes expressed in circulating monocytes jointly contributed to prediction of symptomatic atherosclerotic vascular disease. Incorporating a pathogenic foaming gene set with known risk factors can significantly strengthen the power to predict ASCVD risk. Our programs may facilitate both mechanistic investigations and development of therapeutic and prognostic strategies for ASCVD risk.
Authors: Patricia G Yancey; Anna E Bortnick; Ginny Kellner-Weibel; Margarita de la Llera-Moya; Michael C Phillips; George H Rothblat Journal: Arterioscler Thromb Vasc Biol Date: 2003-01-23 Impact factor: 8.311
Authors: Ralph B D'Agostino; Ramachandran S Vasan; Michael J Pencina; Philip A Wolf; Mark Cobain; Joseph M Massaro; William B Kannel Journal: Circulation Date: 2008-01-22 Impact factor: 29.690
Authors: Anusha N Seneviratne; Jennifer E Cole; Michael E Goddard; Inhye Park; Zahra Mohri; Stephen Sansom; Irina Udalova; Rob Krams; Claudia Monaco Journal: J Mol Cell Cardiol Date: 2015-10-30 Impact factor: 5.000
Authors: Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy Journal: Am J Epidemiol Date: 2002-11-01 Impact factor: 4.897
Authors: Dawn M Fernandez; Adeeb H Rahman; Nicolas F Fernandez; Aleksey Chudnovskiy; El-Ad David Amir; Letizia Amadori; Nayaab S Khan; Christine K Wong; Roza Shamailova; Christopher A Hill; Zichen Wang; Romain Remark; Jennifer R Li; Christian Pina; Christopher Faries; Ahmed J Awad; Noah Moss; Johan L M Bjorkegren; Seunghee Kim-Schulze; Sacha Gnjatic; Avi Ma'ayan; J Mocco; Peter Faries; Miriam Merad; Chiara Giannarelli Journal: Nat Med Date: 2019-10-07 Impact factor: 53.440
Authors: Binod Aryal; Noemi Rotllan; Elisa Araldi; Cristina M Ramírez; Shun He; Benjamin G Chousterman; Ashley M Fenn; Amarylis Wanschel; Julio Madrigal-Matute; Nikhil Warrier; Jose L Martín-Ventura; Filip K Swirski; Yajaira Suárez; Carlos Fernández-Hernando Journal: Nat Commun Date: 2016-07-27 Impact factor: 14.919